A Scheja

Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database

A. J. Tyndall, Bettina Bannert, Paolo Airó et al. · Annals of the Rheumatic Diseases · 2010 · 1.4K citations · Full text

Public Health, Biostatistics, Cardiology +14

Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group

Suzana Jordan, Jörg H. W. Distler, Britta Maurer et al. · Annals of the Rheumatic Diseases · 2014 · 428 citations · Full text

Medicine, Immunology, Pharmacotherapy +13

Mortality and causes of death in a Swedish series of systemic sclerosis patients

Roger Hesselstrand, A Scheja · Annals of the Rheumatic Diseases · 1998 · 249 citations

Medicine, Oncology, Chemotherapy +14

Improved pulmonary function in systemic sclerosis after treatment with cyclophosphamide

Anita Åkesson, A Scheja, Anders Lundin et al. · Arthritis & Rheumatism · 1994 · 152 citations

Medicine, Pharmacology, Pharmacotherapy +16

Presence of CD4+CD8+ double‐positive T cells with very high interleukin‐4 production potential in lesional skin of patients with systemic sclerosis

Yann Parel, Michel Aurrand‐Lions, A Scheja et al. · Arthritis & Rheumatism · 2007 · 139 citations · Full text

Medicine, Dermatology, Immunology +17